pi Search Results


94
Echelon Biosciences arhgef7 sdp
( a ) <t>ARHGEF7</t> (human isoform-a, 646 residues, NM_001113513) domains, structure, and selected residues. The structure is an AlphaFold model (AF-Q14155-1-F1-model_v6_isoform_a) of ARHGEF7 showing the structured SH3, DH, and PH domains with cysteines and nearby residues. ( b ) Accessible surface areas (ASA) of cysteines in ARHGEF7. ( c ) Sequence alignments around C312 in ARHGEF7 orthologs. ( d ) Clickable glutathione approach. Cells expressing a glutathione synthetase mutant (GS M4) synthesize and produce clickable glutathione (N 3 -GSH) using endogenous γGlu-Cys and exogenous azido-Ala. Clickable glutathione forms S-glutathionylation with proteins, which are analyzed after click reactions. ( e - f ) Glutathionylation of ARHGEF7 WT and cysteine mutants in MDA-MB-231 cells in response to high glucose (HG, 25 mM) or low glucose (LG, 5 mM) conditions: cells were incubated for 20 h (n=3). ( g - h ) Glutathionylation of ARHGEF7 constructs in MDA-MB-231 cells upon adding EGF (n=3). EGF was incubated for 20 h. The lysates were used for click reactions with biotin-alkyne and analyzed by western blot with FLAG antibody before (input) and after (eluted) pull-down with streptavidin-agarose. Data represent the mean ± SD. The statistical difference was analyzed by one-way ANOVA and Tukey’s post-hoc test ( e - h ), where *p < 0.03, **p < 0.002, ***p < 0.0002, ****p < 0.0001.
Arhgef7 Sdp, supplied by Echelon Biosciences, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pi/PI(3%2C5)P2+PolyPIPosomes/bio_rxiv__64898__2026__05__01__722049-303-9-22
Average 94 stars, based on 1 article reviews
arhgef7 sdp - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

99
Beyotime dead bacterial staining kit
( a ) <t>ARHGEF7</t> (human isoform-a, 646 residues, NM_001113513) domains, structure, and selected residues. The structure is an AlphaFold model (AF-Q14155-1-F1-model_v6_isoform_a) of ARHGEF7 showing the structured SH3, DH, and PH domains with cysteines and nearby residues. ( b ) Accessible surface areas (ASA) of cysteines in ARHGEF7. ( c ) Sequence alignments around C312 in ARHGEF7 orthologs. ( d ) Clickable glutathione approach. Cells expressing a glutathione synthetase mutant (GS M4) synthesize and produce clickable glutathione (N 3 -GSH) using endogenous γGlu-Cys and exogenous azido-Ala. Clickable glutathione forms S-glutathionylation with proteins, which are analyzed after click reactions. ( e - f ) Glutathionylation of ARHGEF7 WT and cysteine mutants in MDA-MB-231 cells in response to high glucose (HG, 25 mM) or low glucose (LG, 5 mM) conditions: cells were incubated for 20 h (n=3). ( g - h ) Glutathionylation of ARHGEF7 constructs in MDA-MB-231 cells upon adding EGF (n=3). EGF was incubated for 20 h. The lysates were used for click reactions with biotin-alkyne and analyzed by western blot with FLAG antibody before (input) and after (eluted) pull-down with streptavidin-agarose. Data represent the mean ± SD. The statistical difference was analyzed by one-way ANOVA and Tukey’s post-hoc test ( e - h ), where *p < 0.03, **p < 0.002, ***p < 0.0002, ****p < 0.0001.
Dead Bacterial Staining Kit, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pi/LIVE-DEAD+Bacterial+Staining+Kit+with+DMAO+%26+PI/pmc12205665-35-6-18
Average 99 stars, based on 1 article reviews
dead bacterial staining kit - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

96
Elabscience Biotechnology phospho pi3k
Effect of MSCs-EVs, rapamycin, and quercetin on ( A ) phosphorylation of mTOR, <t>PI3K,</t> and AKT as detected by western blot analysis, ( B - D ) Intensity of immunoreactivity of selected proteins as quantified by densitometry. Results are expressed as mean ± SEM. **significant vs. Control group at p<0.01, **** at p<0.0001, # significant vs. OF group at p<0.05, ## at p<0.01, ### at p<0.001, #### at p<0.0001, & significant vs. OF + Rapamycin group at p<0.05
Phospho Pi3k, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pi/Phospho-PI+3+kinase+p85+alpha+-gamma+(Tyr467-199)+Polyclonal+Antibody/pmc11552115-107-42-44
Average 96 stars, based on 1 article reviews
phospho pi3k - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

94
R&D Systems il 1 b
Effect of MSCs-EVs, rapamycin, and quercetin on ( A ) phosphorylation of mTOR, <t>PI3K,</t> and AKT as detected by western blot analysis, ( B - D ) Intensity of immunoreactivity of selected proteins as quantified by densitometry. Results are expressed as mean ± SEM. **significant vs. Control group at p<0.01, **** at p<0.0001, # significant vs. OF group at p<0.05, ## at p<0.01, ### at p<0.001, #### at p<0.0001, & significant vs. OF + Rapamycin group at p<0.05
Il 1 B, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pi/Recombinant+Porcine+IL-1+beta%2FIL-1F2+Protein/pm16604540-40-11-15
Average 94 stars, based on 1 article reviews
il 1 b - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

91
R&D Systems human tfpi
Effect of MSCs-EVs, rapamycin, and quercetin on ( A ) phosphorylation of mTOR, <t>PI3K,</t> and AKT as detected by western blot analysis, ( B - D ) Intensity of immunoreactivity of selected proteins as quantified by densitometry. Results are expressed as mean ± SEM. **significant vs. Control group at p<0.01, **** at p<0.0001, # significant vs. OF group at p<0.05, ## at p<0.01, ### at p<0.001, #### at p<0.0001, & significant vs. OF + Rapamycin group at p<0.05
Human Tfpi, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pi/Recombinant+Human+TFPI+Protein%2C+CF/pm25849335-49-2-7
Average 91 stars, based on 1 article reviews
human tfpi - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

91
R&D Systems recombinant porcine il 1α
Effect of MSCs-EVs, rapamycin, and quercetin on ( A ) phosphorylation of mTOR, <t>PI3K,</t> and AKT as detected by western blot analysis, ( B - D ) Intensity of immunoreactivity of selected proteins as quantified by densitometry. Results are expressed as mean ± SEM. **significant vs. Control group at p<0.01, **** at p<0.0001, # significant vs. OF group at p<0.05, ## at p<0.01, ### at p<0.001, #### at p<0.0001, & significant vs. OF + Rapamycin group at p<0.05
Recombinant Porcine Il 1α, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pi/Recombinant+Porcine+IL-10+Protein/pmc03217044-130-7-10
Average 91 stars, based on 1 article reviews
recombinant porcine il 1α - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

90
R&D Systems recombinant serpina12
(A) Representative images and BODIPY® staining quantification show pretreatment with <t>SerpinA12</t> protects against lipid droplet formation induced by EtOH (n=6, 63x, p<0.05, one way ANOVA). (B) WB and densitometry quantification shows that EtOH induces a reduction in the phosphorylation of AMPK compared to control. SerpinA12 induces phosphorylation of AMPK, even in the presence of EtOH, and this effect is blunted by the presence of AMPK inhibitor (duplicates, n=6, *p<0.05, one way ANOVA). (C) Representative images and BODIPY staining quantification show protection of SerpinA12 against EtOH-induced lipid droplet formation on treatment with SerpinA12 ± EtOH. This effect was blunted by using an AMPK inhibitor (n=6, 63x, *p<0.05, one way ANOVA). (D) EtOH induces key lipogenic genes involved in hepatic lipid homeostasis, and this effect is reduced by SerpinA12. The protective effect of SerpinA12 is attenuated by an AMPK inhibitor (n=6, *p<0.05 compared to control, #p<0.05 compared to EtOH alone, one way ANOVA). (E) Human hepatocytes treated with supernatant from human HSC with a siRNA-mediated knockdown of SerpinA12 ± EtOH. EtOH ± supernatant from siRNA-mediated knockdown of SerpinA12 increases expression of SREBP-1c, FASN, and SCD1 compared to EtOH in siControl cells (n=9, *p<0.05 compared to control, #p<0.05 compared to EtOH alone, one way ANOVA).
Recombinant Serpina12, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pi/Recombinant+Human+Serpin+A12+Protein%2C+CF/pmc07305991-144-20-22
Average 90 stars, based on 1 article reviews
recombinant serpina12 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

94
Elabscience Biotechnology 488 pi apoptosis kit
(A) Representative images and BODIPY® staining quantification show pretreatment with <t>SerpinA12</t> protects against lipid droplet formation induced by EtOH (n=6, 63x, p<0.05, one way ANOVA). (B) WB and densitometry quantification shows that EtOH induces a reduction in the phosphorylation of AMPK compared to control. SerpinA12 induces phosphorylation of AMPK, even in the presence of EtOH, and this effect is blunted by the presence of AMPK inhibitor (duplicates, n=6, *p<0.05, one way ANOVA). (C) Representative images and BODIPY staining quantification show protection of SerpinA12 against EtOH-induced lipid droplet formation on treatment with SerpinA12 ± EtOH. This effect was blunted by using an AMPK inhibitor (n=6, 63x, *p<0.05, one way ANOVA). (D) EtOH induces key lipogenic genes involved in hepatic lipid homeostasis, and this effect is reduced by SerpinA12. The protective effect of SerpinA12 is attenuated by an AMPK inhibitor (n=6, *p<0.05 compared to control, #p<0.05 compared to EtOH alone, one way ANOVA). (E) Human hepatocytes treated with supernatant from human HSC with a siRNA-mediated knockdown of SerpinA12 ± EtOH. EtOH ± supernatant from siRNA-mediated knockdown of SerpinA12 increases expression of SREBP-1c, FASN, and SCD1 compared to EtOH in siControl cells (n=9, *p<0.05 compared to control, #p<0.05 compared to EtOH alone, one way ANOVA).
488 Pi Apoptosis Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pi/Annexin+V-Elab+Fluor+488%2FPI+Apoptosis+Kit/pm39002796-106-17-21
Average 94 stars, based on 1 article reviews
488 pi apoptosis kit - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

99
Beyotime necrosis detection kit
(A) Representative images and BODIPY® staining quantification show pretreatment with <t>SerpinA12</t> protects against lipid droplet formation induced by EtOH (n=6, 63x, p<0.05, one way ANOVA). (B) WB and densitometry quantification shows that EtOH induces a reduction in the phosphorylation of AMPK compared to control. SerpinA12 induces phosphorylation of AMPK, even in the presence of EtOH, and this effect is blunted by the presence of AMPK inhibitor (duplicates, n=6, *p<0.05, one way ANOVA). (C) Representative images and BODIPY staining quantification show protection of SerpinA12 against EtOH-induced lipid droplet formation on treatment with SerpinA12 ± EtOH. This effect was blunted by using an AMPK inhibitor (n=6, 63x, *p<0.05, one way ANOVA). (D) EtOH induces key lipogenic genes involved in hepatic lipid homeostasis, and this effect is reduced by SerpinA12. The protective effect of SerpinA12 is attenuated by an AMPK inhibitor (n=6, *p<0.05 compared to control, #p<0.05 compared to EtOH alone, one way ANOVA). (E) Human hepatocytes treated with supernatant from human HSC with a siRNA-mediated knockdown of SerpinA12 ± EtOH. EtOH ± supernatant from siRNA-mediated knockdown of SerpinA12 increases expression of SREBP-1c, FASN, and SCD1 compared to EtOH in siControl cells (n=9, *p<0.05 compared to control, #p<0.05 compared to EtOH alone, one way ANOVA).
Necrosis Detection Kit, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pi/Apoptosis+and+Necrosis+Detection+Kit+with+YO-PRO-1+and+PI/pmc12670209-73-18-29
Average 99 stars, based on 1 article reviews
necrosis detection kit - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

94
Beijing Solarbio Science 647 pi apoptosis detection kit
(A) Representative images and BODIPY® staining quantification show pretreatment with <t>SerpinA12</t> protects against lipid droplet formation induced by EtOH (n=6, 63x, p<0.05, one way ANOVA). (B) WB and densitometry quantification shows that EtOH induces a reduction in the phosphorylation of AMPK compared to control. SerpinA12 induces phosphorylation of AMPK, even in the presence of EtOH, and this effect is blunted by the presence of AMPK inhibitor (duplicates, n=6, *p<0.05, one way ANOVA). (C) Representative images and BODIPY staining quantification show protection of SerpinA12 against EtOH-induced lipid droplet formation on treatment with SerpinA12 ± EtOH. This effect was blunted by using an AMPK inhibitor (n=6, 63x, *p<0.05, one way ANOVA). (D) EtOH induces key lipogenic genes involved in hepatic lipid homeostasis, and this effect is reduced by SerpinA12. The protective effect of SerpinA12 is attenuated by an AMPK inhibitor (n=6, *p<0.05 compared to control, #p<0.05 compared to EtOH alone, one way ANOVA). (E) Human hepatocytes treated with supernatant from human HSC with a siRNA-mediated knockdown of SerpinA12 ± EtOH. EtOH ± supernatant from siRNA-mediated knockdown of SerpinA12 increases expression of SREBP-1c, FASN, and SCD1 compared to EtOH in siControl cells (n=9, *p<0.05 compared to control, #p<0.05 compared to EtOH alone, one way ANOVA).
647 Pi Apoptosis Detection Kit, supplied by Beijing Solarbio Science, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pi/AnnexinV-Alexa+Fluor+647%2FPI+Apoptosis+detection+Kit/pmc11833140-328-9-14
Average 94 stars, based on 1 article reviews
647 pi apoptosis detection kit - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
R&D Systems human recombinant serpine2
(A) Representative images and BODIPY® staining quantification show pretreatment with <t>SerpinA12</t> protects against lipid droplet formation induced by EtOH (n=6, 63x, p<0.05, one way ANOVA). (B) WB and densitometry quantification shows that EtOH induces a reduction in the phosphorylation of AMPK compared to control. SerpinA12 induces phosphorylation of AMPK, even in the presence of EtOH, and this effect is blunted by the presence of AMPK inhibitor (duplicates, n=6, *p<0.05, one way ANOVA). (C) Representative images and BODIPY staining quantification show protection of SerpinA12 against EtOH-induced lipid droplet formation on treatment with SerpinA12 ± EtOH. This effect was blunted by using an AMPK inhibitor (n=6, 63x, *p<0.05, one way ANOVA). (D) EtOH induces key lipogenic genes involved in hepatic lipid homeostasis, and this effect is reduced by SerpinA12. The protective effect of SerpinA12 is attenuated by an AMPK inhibitor (n=6, *p<0.05 compared to control, #p<0.05 compared to EtOH alone, one way ANOVA). (E) Human hepatocytes treated with supernatant from human HSC with a siRNA-mediated knockdown of SerpinA12 ± EtOH. EtOH ± supernatant from siRNA-mediated knockdown of SerpinA12 increases expression of SREBP-1c, FASN, and SCD1 compared to EtOH in siControl cells (n=9, *p<0.05 compared to control, #p<0.05 compared to EtOH alone, one way ANOVA).
Human Recombinant Serpine2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pi/Recombinant+Human+Serpin+E2%2FPN1+Protein%2C+CF/pm26305372-50-0-6
Average 93 stars, based on 1 article reviews
human recombinant serpine2 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
R&D Systems recombinant human slpi
(A) Representative images and BODIPY® staining quantification show pretreatment with <t>SerpinA12</t> protects against lipid droplet formation induced by EtOH (n=6, 63x, p<0.05, one way ANOVA). (B) WB and densitometry quantification shows that EtOH induces a reduction in the phosphorylation of AMPK compared to control. SerpinA12 induces phosphorylation of AMPK, even in the presence of EtOH, and this effect is blunted by the presence of AMPK inhibitor (duplicates, n=6, *p<0.05, one way ANOVA). (C) Representative images and BODIPY staining quantification show protection of SerpinA12 against EtOH-induced lipid droplet formation on treatment with SerpinA12 ± EtOH. This effect was blunted by using an AMPK inhibitor (n=6, 63x, *p<0.05, one way ANOVA). (D) EtOH induces key lipogenic genes involved in hepatic lipid homeostasis, and this effect is reduced by SerpinA12. The protective effect of SerpinA12 is attenuated by an AMPK inhibitor (n=6, *p<0.05 compared to control, #p<0.05 compared to EtOH alone, one way ANOVA). (E) Human hepatocytes treated with supernatant from human HSC with a siRNA-mediated knockdown of SerpinA12 ± EtOH. EtOH ± supernatant from siRNA-mediated knockdown of SerpinA12 increases expression of SREBP-1c, FASN, and SCD1 compared to EtOH in siControl cells (n=9, *p<0.05 compared to control, #p<0.05 compared to EtOH alone, one way ANOVA).
Recombinant Human Slpi, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pi/Recombinant+Human+SLPI+Protein%2C+CF/pmc03152651-121-0-3
Average 93 stars, based on 1 article reviews
recombinant human slpi - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

Image Search Results


( a ) ARHGEF7 (human isoform-a, 646 residues, NM_001113513) domains, structure, and selected residues. The structure is an AlphaFold model (AF-Q14155-1-F1-model_v6_isoform_a) of ARHGEF7 showing the structured SH3, DH, and PH domains with cysteines and nearby residues. ( b ) Accessible surface areas (ASA) of cysteines in ARHGEF7. ( c ) Sequence alignments around C312 in ARHGEF7 orthologs. ( d ) Clickable glutathione approach. Cells expressing a glutathione synthetase mutant (GS M4) synthesize and produce clickable glutathione (N 3 -GSH) using endogenous γGlu-Cys and exogenous azido-Ala. Clickable glutathione forms S-glutathionylation with proteins, which are analyzed after click reactions. ( e - f ) Glutathionylation of ARHGEF7 WT and cysteine mutants in MDA-MB-231 cells in response to high glucose (HG, 25 mM) or low glucose (LG, 5 mM) conditions: cells were incubated for 20 h (n=3). ( g - h ) Glutathionylation of ARHGEF7 constructs in MDA-MB-231 cells upon adding EGF (n=3). EGF was incubated for 20 h. The lysates were used for click reactions with biotin-alkyne and analyzed by western blot with FLAG antibody before (input) and after (eluted) pull-down with streptavidin-agarose. Data represent the mean ± SD. The statistical difference was analyzed by one-way ANOVA and Tukey’s post-hoc test ( e - h ), where *p < 0.03, **p < 0.002, ***p < 0.0002, ****p < 0.0001.

Journal: bioRxiv

Article Title: ARHGEF7 S-glutathionylation promotes cancer cell migration through Rac1 activation

doi: 10.64898/2026.05.01.722049

Figure Lengend Snippet: ( a ) ARHGEF7 (human isoform-a, 646 residues, NM_001113513) domains, structure, and selected residues. The structure is an AlphaFold model (AF-Q14155-1-F1-model_v6_isoform_a) of ARHGEF7 showing the structured SH3, DH, and PH domains with cysteines and nearby residues. ( b ) Accessible surface areas (ASA) of cysteines in ARHGEF7. ( c ) Sequence alignments around C312 in ARHGEF7 orthologs. ( d ) Clickable glutathione approach. Cells expressing a glutathione synthetase mutant (GS M4) synthesize and produce clickable glutathione (N 3 -GSH) using endogenous γGlu-Cys and exogenous azido-Ala. Clickable glutathione forms S-glutathionylation with proteins, which are analyzed after click reactions. ( e - f ) Glutathionylation of ARHGEF7 WT and cysteine mutants in MDA-MB-231 cells in response to high glucose (HG, 25 mM) or low glucose (LG, 5 mM) conditions: cells were incubated for 20 h (n=3). ( g - h ) Glutathionylation of ARHGEF7 constructs in MDA-MB-231 cells upon adding EGF (n=3). EGF was incubated for 20 h. The lysates were used for click reactions with biotin-alkyne and analyzed by western blot with FLAG antibody before (input) and after (eluted) pull-down with streptavidin-agarose. Data represent the mean ± SD. The statistical difference was analyzed by one-way ANOVA and Tukey’s post-hoc test ( e - h ), where *p < 0.03, **p < 0.002, ***p < 0.0002, ****p < 0.0001.

Article Snippet: For binding analysis with PI(3,5)P 2 , dialyzed glutathionylated ARHGEF7 SDP (WT and C312S) was then incubated with biotinylated PI(3,5)P 2 PolyPIPosomes (Echelon Biosciences, Cat# Y-P035) at room temperature for 30 min.

Techniques: Sequencing, Expressing, Mutagenesis, Incubation, Construct, Western Blot

( a ) A potential mode of ARHGEF7 activation by S-glutathionylation. In the absence of ROS, the DH-PH active site is relatively closed, and the SH3 domain stays bound to the DH-PH or its binding partners, Rac1 or PAK1, through the C-terminal proline-rich sequence (PRS) in Rac1 and PAK1 (left). Upon ROS generation, ARHGEF7 is glutathionylated at C312 at the PH domain, which opens the active site in the DH-PH domains to which SH3-bound Rac1-GDP binds for GDP-GTP exchange (middle). Rac1 activation follows, resulting in PAK1 phosphorylation and activation (right). ( b ) A model for ARHGEF7 activation in cells. In the absence of ROS, ARHGEF7, in complex with GIT1, may be associated with none or PAK1 in cells, without significant Rac1 activation. In the presence of ROS, glutathionylated ARHGEF7/GIT1/PAK1 complex is recruited to the nascent focal adhesion at the protrusion, where PAK1 is dissociated, and glutathionylated ARHGEF7 increases the binding to Rac1 for Rac1 activation. Active Rac1 increases phosphorylation and activation of PAK1. The active Rac1 and PAK1 activate their downstream signaling, including Arp2/3, LIMK-cofilin, and MEK1/2-ERK1, which increases branching and polymerization of actin filaments, lamellipodia formation, and cell migration.

Journal: bioRxiv

Article Title: ARHGEF7 S-glutathionylation promotes cancer cell migration through Rac1 activation

doi: 10.64898/2026.05.01.722049

Figure Lengend Snippet: ( a ) A potential mode of ARHGEF7 activation by S-glutathionylation. In the absence of ROS, the DH-PH active site is relatively closed, and the SH3 domain stays bound to the DH-PH or its binding partners, Rac1 or PAK1, through the C-terminal proline-rich sequence (PRS) in Rac1 and PAK1 (left). Upon ROS generation, ARHGEF7 is glutathionylated at C312 at the PH domain, which opens the active site in the DH-PH domains to which SH3-bound Rac1-GDP binds for GDP-GTP exchange (middle). Rac1 activation follows, resulting in PAK1 phosphorylation and activation (right). ( b ) A model for ARHGEF7 activation in cells. In the absence of ROS, ARHGEF7, in complex with GIT1, may be associated with none or PAK1 in cells, without significant Rac1 activation. In the presence of ROS, glutathionylated ARHGEF7/GIT1/PAK1 complex is recruited to the nascent focal adhesion at the protrusion, where PAK1 is dissociated, and glutathionylated ARHGEF7 increases the binding to Rac1 for Rac1 activation. Active Rac1 increases phosphorylation and activation of PAK1. The active Rac1 and PAK1 activate their downstream signaling, including Arp2/3, LIMK-cofilin, and MEK1/2-ERK1, which increases branching and polymerization of actin filaments, lamellipodia formation, and cell migration.

Article Snippet: For binding analysis with PI(3,5)P 2 , dialyzed glutathionylated ARHGEF7 SDP (WT and C312S) was then incubated with biotinylated PI(3,5)P 2 PolyPIPosomes (Echelon Biosciences, Cat# Y-P035) at room temperature for 30 min.

Techniques: Activation Assay, Binding Assay, Sequencing, Phospho-proteomics, Migration

( a - b ) In-vitro scratch migration analysis of MDA-MB-231 cells expressing ARHGEF7 construct in high glucose (HG, 25 mM) or low glucose (LG, 5 mM) conditions (n=4) ( a ) or in response to EGF (n=9) ( b ). Yellow indicates areas without cells. ( c - d ) Transwell invasion analysis of MDA-MB-231 cells expressing ARHGEF7 constructs in HL or LG (n=3) ( c ) or upon incubating EGF (n=3) ( d ). Cells were incubated in HG or LG ( a , c ) or with EGF for 20 h ( b , d ). A scale bar = 500 μm. Data represent the mean ± SD. The statistical difference was analyzed by two-way ANOVA and Tukey’s post-hoc test ( a - d ), where *p < 0.03, **p < 0.002, ***p < 0.0002, ****p < 0.0001.

Journal: bioRxiv

Article Title: ARHGEF7 S-glutathionylation promotes cancer cell migration through Rac1 activation

doi: 10.64898/2026.05.01.722049

Figure Lengend Snippet: ( a - b ) In-vitro scratch migration analysis of MDA-MB-231 cells expressing ARHGEF7 construct in high glucose (HG, 25 mM) or low glucose (LG, 5 mM) conditions (n=4) ( a ) or in response to EGF (n=9) ( b ). Yellow indicates areas without cells. ( c - d ) Transwell invasion analysis of MDA-MB-231 cells expressing ARHGEF7 constructs in HL or LG (n=3) ( c ) or upon incubating EGF (n=3) ( d ). Cells were incubated in HG or LG ( a , c ) or with EGF for 20 h ( b , d ). A scale bar = 500 μm. Data represent the mean ± SD. The statistical difference was analyzed by two-way ANOVA and Tukey’s post-hoc test ( a - d ), where *p < 0.03, **p < 0.002, ***p < 0.0002, ****p < 0.0001.

Article Snippet: For binding analysis with PI(3,5)P 2 , dialyzed glutathionylated ARHGEF7 SDP (WT and C312S) was then incubated with biotinylated PI(3,5)P 2 PolyPIPosomes (Echelon Biosciences, Cat# Y-P035) at room temperature for 30 min.

Techniques: In Vitro, Migration, Expressing, Construct, Incubation

Analysis of ARHGEF7 protein interactions and Rac1-PAK1 downstream signaling. MDA-MB-231 cells expressing ARHGEF7 WT or C312S were incubated in high glucose (HG, 25 mM) or low glucose (LG, 5 mM) for 20 h. ( a ) ARHGEF7 S-glutathionylation increases its binding to Rac1. ARHGEF7 co-immunoprecipitation (co-IP) with Rac1 and PAK1 (n=3). ( b ) Rac1 is activated upon ARHGEF7 S-glutathionylation. Active Rac1 was enriched by purified GST-PBD (p21-binding domain derived from PAK1) and analyzed by western blots (n=3). ( c ) ARHGEF7 S-glutathionylation activates PAK1 and its downstream signaling. Phosphorylation levels of PAK1, LIMK1, and MEK1/2 were analyzed by western blot (n=3). ( d ) ARHGEF7 S-glutathionylation increases Rac1 localization at the cell periphery. The co-localization images of ARHGEF7 and Rac1 (left). Cells were fixed and analyzed by antibodies to FLAG (green) and Rac1/Cdc42 (red) (n=10 images). White arrows indicate the intense co-localization of ARHGEF7 and Rac1. Pearson’s correlation coefficients (right) were calculated after Intermodes thresholding to select for colocalization of ARHGEF7 and Rac1 at the cell periphery (see also Figure S6). A scale bar = 10 μm. Data represent the mean ± SD. The statistical difference was analyzed by one-way ANOVA and Tukey’s post-hoc test ( a-d ), where *p < 0.03, **p < 0.002, ***p < 0.0002, ****p < 0.0001.

Journal: bioRxiv

Article Title: ARHGEF7 S-glutathionylation promotes cancer cell migration through Rac1 activation

doi: 10.64898/2026.05.01.722049

Figure Lengend Snippet: Analysis of ARHGEF7 protein interactions and Rac1-PAK1 downstream signaling. MDA-MB-231 cells expressing ARHGEF7 WT or C312S were incubated in high glucose (HG, 25 mM) or low glucose (LG, 5 mM) for 20 h. ( a ) ARHGEF7 S-glutathionylation increases its binding to Rac1. ARHGEF7 co-immunoprecipitation (co-IP) with Rac1 and PAK1 (n=3). ( b ) Rac1 is activated upon ARHGEF7 S-glutathionylation. Active Rac1 was enriched by purified GST-PBD (p21-binding domain derived from PAK1) and analyzed by western blots (n=3). ( c ) ARHGEF7 S-glutathionylation activates PAK1 and its downstream signaling. Phosphorylation levels of PAK1, LIMK1, and MEK1/2 were analyzed by western blot (n=3). ( d ) ARHGEF7 S-glutathionylation increases Rac1 localization at the cell periphery. The co-localization images of ARHGEF7 and Rac1 (left). Cells were fixed and analyzed by antibodies to FLAG (green) and Rac1/Cdc42 (red) (n=10 images). White arrows indicate the intense co-localization of ARHGEF7 and Rac1. Pearson’s correlation coefficients (right) were calculated after Intermodes thresholding to select for colocalization of ARHGEF7 and Rac1 at the cell periphery (see also Figure S6). A scale bar = 10 μm. Data represent the mean ± SD. The statistical difference was analyzed by one-way ANOVA and Tukey’s post-hoc test ( a-d ), where *p < 0.03, **p < 0.002, ***p < 0.0002, ****p < 0.0001.

Article Snippet: For binding analysis with PI(3,5)P 2 , dialyzed glutathionylated ARHGEF7 SDP (WT and C312S) was then incubated with biotinylated PI(3,5)P 2 PolyPIPosomes (Echelon Biosciences, Cat# Y-P035) at room temperature for 30 min.

Techniques: Expressing, Incubation, Binding Assay, Immunoprecipitation, Co-Immunoprecipitation Assay, Purification, Derivative Assay, Western Blot, Phospho-proteomics

( a - c ) In vitro binding analysis of ARHGEF7 constructs (DP or SDP) with GST-Rac1. Purified ARHGEF7 constructs (DP and SDP) were incubated with oxidized glutathione (GSSG) to induce S-glutathionylation. Following dialysis, ARHGEF7 constructs were incubated with GST-Rac1 immobilized on glutathione-Sepharose. GST-Rac1 and ARHGEF7 constructs were analyzed by Western blot before and after GST pull-down. ( a ) Comparison of Rac1 binding to ARHGEF7 DP WT and ARHGEF7 SDP WT (n=3). ( b ) Comparison of Rac1 binding to ARHGEF7 SDP WT and ARHGEF7 SDP C312S (n=3). ( c ). Comparison of ARHGEF7 SDP WT binding to Rac1 with different active site states (none, GDP, GTPγS) (n=3). ( d ) In vitro binding analysis of ARHGEF7 with PI(3,5)P 2 . Purified ARHGEF7 SDP treated without and with GSSG were incubated with biotinylated PI(3,5)P 2 on micelle. Bound ARHGEF7 SDP constructs were analyzed by Coomassie stain (CM) (n=3). ( e - f ) ARHGEF7 increases its GDP-GTP exchange rate upon S-glutathionylation. Different purified ARHGEF7 constructs were incubated with GSSG and used for enzyme kinetics. Rates were determined by a loss of fluorescence when Bodipy-GDP bound to Rac1 dissociates from Rac1. ( e ) Rate measurement by purified ARHGEF7 DP or SDP constructs without or with incubation of GSSG. Rates were determined by increasing enzyme concentration (n=3) (left) and substrate concentration (Michaelis-Menten) (n=3) (right). ( f ) Rate measurement by a full-length ARHGEF7 construct without or with glutathionylation. FLAG-ARHGEF7 purified by affinity purification was incubated with GSSG and used to measure rates (n=4). Data represent the mean ± SD. The statistical difference was analyzed by one-way ANOVA and Tukey’s post-hoc test ( a-d ) or unpaired t-test ( f ), where *p < 0.03, **p < 0.002, ***p < 0.0002, ****p < 0.0001.

Journal: bioRxiv

Article Title: ARHGEF7 S-glutathionylation promotes cancer cell migration through Rac1 activation

doi: 10.64898/2026.05.01.722049

Figure Lengend Snippet: ( a - c ) In vitro binding analysis of ARHGEF7 constructs (DP or SDP) with GST-Rac1. Purified ARHGEF7 constructs (DP and SDP) were incubated with oxidized glutathione (GSSG) to induce S-glutathionylation. Following dialysis, ARHGEF7 constructs were incubated with GST-Rac1 immobilized on glutathione-Sepharose. GST-Rac1 and ARHGEF7 constructs were analyzed by Western blot before and after GST pull-down. ( a ) Comparison of Rac1 binding to ARHGEF7 DP WT and ARHGEF7 SDP WT (n=3). ( b ) Comparison of Rac1 binding to ARHGEF7 SDP WT and ARHGEF7 SDP C312S (n=3). ( c ). Comparison of ARHGEF7 SDP WT binding to Rac1 with different active site states (none, GDP, GTPγS) (n=3). ( d ) In vitro binding analysis of ARHGEF7 with PI(3,5)P 2 . Purified ARHGEF7 SDP treated without and with GSSG were incubated with biotinylated PI(3,5)P 2 on micelle. Bound ARHGEF7 SDP constructs were analyzed by Coomassie stain (CM) (n=3). ( e - f ) ARHGEF7 increases its GDP-GTP exchange rate upon S-glutathionylation. Different purified ARHGEF7 constructs were incubated with GSSG and used for enzyme kinetics. Rates were determined by a loss of fluorescence when Bodipy-GDP bound to Rac1 dissociates from Rac1. ( e ) Rate measurement by purified ARHGEF7 DP or SDP constructs without or with incubation of GSSG. Rates were determined by increasing enzyme concentration (n=3) (left) and substrate concentration (Michaelis-Menten) (n=3) (right). ( f ) Rate measurement by a full-length ARHGEF7 construct without or with glutathionylation. FLAG-ARHGEF7 purified by affinity purification was incubated with GSSG and used to measure rates (n=4). Data represent the mean ± SD. The statistical difference was analyzed by one-way ANOVA and Tukey’s post-hoc test ( a-d ) or unpaired t-test ( f ), where *p < 0.03, **p < 0.002, ***p < 0.0002, ****p < 0.0001.

Article Snippet: For binding analysis with PI(3,5)P 2 , dialyzed glutathionylated ARHGEF7 SDP (WT and C312S) was then incubated with biotinylated PI(3,5)P 2 PolyPIPosomes (Echelon Biosciences, Cat# Y-P035) at room temperature for 30 min.

Techniques: In Vitro, Binding Assay, Construct, Purification, Incubation, Western Blot, Comparison, Staining, Fluorescence, Concentration Assay, Affinity Purification

Effect of MSCs-EVs, rapamycin, and quercetin on ( A ) phosphorylation of mTOR, PI3K, and AKT as detected by western blot analysis, ( B - D ) Intensity of immunoreactivity of selected proteins as quantified by densitometry. Results are expressed as mean ± SEM. **significant vs. Control group at p<0.01, **** at p<0.0001, # significant vs. OF group at p<0.05, ## at p<0.01, ### at p<0.001, #### at p<0.0001, & significant vs. OF + Rapamycin group at p<0.05

Journal: Journal of Ovarian Research

Article Title: MSCs–derived EVs protect against chemotherapy-induced ovarian toxicity: role of PI3K/AKT/mTOR axis

doi: 10.1186/s13048-024-01545-7

Figure Lengend Snippet: Effect of MSCs-EVs, rapamycin, and quercetin on ( A ) phosphorylation of mTOR, PI3K, and AKT as detected by western blot analysis, ( B - D ) Intensity of immunoreactivity of selected proteins as quantified by densitometry. Results are expressed as mean ± SEM. **significant vs. Control group at p<0.01, **** at p<0.0001, # significant vs. OF group at p<0.05, ## at p<0.01, ### at p<0.001, #### at p<0.0001, & significant vs. OF + Rapamycin group at p<0.05

Article Snippet: Next, the blots were incubated with the appropriate primary antibodies for an entire night at 4 °C, PTEN (E-AB-63495, Elabscience, USA), FOXO3 (NBP2-16521, Novus Biologicals USA), mTOR (sc-517464, Santa Cruz Biotechnology, USA), Phospho-mTOR (sc-293133, Santa Cruz Biotechnology, USA), PI3K (E-AB-64202, Elabscience, USA), Phospho-PI3K (E-AB-20966, Elabscience, USA), AKT (E-AB-15441, Elabscience, USA), Phospho-AKT (E-AB-20804, Elabscience, USA), β-actin (E-AB-20031, Elabscience, USA).

Techniques: Phospho-proteomics, Western Blot, Control

(A) Representative images and BODIPY® staining quantification show pretreatment with SerpinA12 protects against lipid droplet formation induced by EtOH (n=6, 63x, p<0.05, one way ANOVA). (B) WB and densitometry quantification shows that EtOH induces a reduction in the phosphorylation of AMPK compared to control. SerpinA12 induces phosphorylation of AMPK, even in the presence of EtOH, and this effect is blunted by the presence of AMPK inhibitor (duplicates, n=6, *p<0.05, one way ANOVA). (C) Representative images and BODIPY staining quantification show protection of SerpinA12 against EtOH-induced lipid droplet formation on treatment with SerpinA12 ± EtOH. This effect was blunted by using an AMPK inhibitor (n=6, 63x, *p<0.05, one way ANOVA). (D) EtOH induces key lipogenic genes involved in hepatic lipid homeostasis, and this effect is reduced by SerpinA12. The protective effect of SerpinA12 is attenuated by an AMPK inhibitor (n=6, *p<0.05 compared to control, #p<0.05 compared to EtOH alone, one way ANOVA). (E) Human hepatocytes treated with supernatant from human HSC with a siRNA-mediated knockdown of SerpinA12 ± EtOH. EtOH ± supernatant from siRNA-mediated knockdown of SerpinA12 increases expression of SREBP-1c, FASN, and SCD1 compared to EtOH in siControl cells (n=9, *p<0.05 compared to control, #p<0.05 compared to EtOH alone, one way ANOVA).

Journal: Journal of hepatology

Article Title: Hepatic stellate cell activation promotes alcohol-induced steatohepatitis through Igfbp3 and SerpinA12

doi: 10.1016/j.jhep.2020.02.005

Figure Lengend Snippet: (A) Representative images and BODIPY® staining quantification show pretreatment with SerpinA12 protects against lipid droplet formation induced by EtOH (n=6, 63x, p<0.05, one way ANOVA). (B) WB and densitometry quantification shows that EtOH induces a reduction in the phosphorylation of AMPK compared to control. SerpinA12 induces phosphorylation of AMPK, even in the presence of EtOH, and this effect is blunted by the presence of AMPK inhibitor (duplicates, n=6, *p<0.05, one way ANOVA). (C) Representative images and BODIPY staining quantification show protection of SerpinA12 against EtOH-induced lipid droplet formation on treatment with SerpinA12 ± EtOH. This effect was blunted by using an AMPK inhibitor (n=6, 63x, *p<0.05, one way ANOVA). (D) EtOH induces key lipogenic genes involved in hepatic lipid homeostasis, and this effect is reduced by SerpinA12. The protective effect of SerpinA12 is attenuated by an AMPK inhibitor (n=6, *p<0.05 compared to control, #p<0.05 compared to EtOH alone, one way ANOVA). (E) Human hepatocytes treated with supernatant from human HSC with a siRNA-mediated knockdown of SerpinA12 ± EtOH. EtOH ± supernatant from siRNA-mediated knockdown of SerpinA12 increases expression of SREBP-1c, FASN, and SCD1 compared to EtOH in siControl cells (n=9, *p<0.05 compared to control, #p<0.05 compared to EtOH alone, one way ANOVA).

Article Snippet: Compounds used were murine or human recombinant Igfbp3 (R&D systems, 0.3 μg/mL), Cytochalasin D (Sigma-Aldrich, 1:1000), PP2 (Sigma-Aldrich, 10 uM), recombinant SerpinA12 (R&Dsystems, 100 ng/mL), Akt inhibitor (Tocris, Akti-1/2, 250 nM), PQ-401 (Tocris, 10uM) and AMPK inhibitor (Tocris, Dorsomorphin dihydrochloride, 20 uM).

Techniques: Staining, Expressing

(A) Representative BODIPY® staining images and quantification from HepG2Cyp2E1 cells treated with (I) medium, (II) control HSC supernatant, (III) siRNA mediated NRP-1 knockdown HSC supernatant. (III) shows decreased lipid droplet formation in vitro (n=6–9, 63X, one-way ANOVA). (B) Top ten down/upregulated molecules from adipokine and inflammatory protein array from NRP-1 KD HSC supernatant compared to controls. IGFBP3 and SerpinA12 were the most significantly decreased and increased proteins respectively (n=3, p<0.05, unpaired t-test). (C) Igfbp3 mRNA and protein expression in NRP-1 KD HSC is lower than human WT HSC on qPCR and WB (n=6–9, p<0.05, unpaired t-test). (D) SerpinA12 mRNA expression in NRP-1 KD HSC is higher than human WT HSC (n=6–9, p<0.05, unpaired t-test).

Journal: Journal of hepatology

Article Title: Hepatic stellate cell activation promotes alcohol-induced steatohepatitis through Igfbp3 and SerpinA12

doi: 10.1016/j.jhep.2020.02.005

Figure Lengend Snippet: (A) Representative BODIPY® staining images and quantification from HepG2Cyp2E1 cells treated with (I) medium, (II) control HSC supernatant, (III) siRNA mediated NRP-1 knockdown HSC supernatant. (III) shows decreased lipid droplet formation in vitro (n=6–9, 63X, one-way ANOVA). (B) Top ten down/upregulated molecules from adipokine and inflammatory protein array from NRP-1 KD HSC supernatant compared to controls. IGFBP3 and SerpinA12 were the most significantly decreased and increased proteins respectively (n=3, p<0.05, unpaired t-test). (C) Igfbp3 mRNA and protein expression in NRP-1 KD HSC is lower than human WT HSC on qPCR and WB (n=6–9, p<0.05, unpaired t-test). (D) SerpinA12 mRNA expression in NRP-1 KD HSC is higher than human WT HSC (n=6–9, p<0.05, unpaired t-test).

Article Snippet: Compounds used were murine or human recombinant Igfbp3 (R&D systems, 0.3 μg/mL), Cytochalasin D (Sigma-Aldrich, 1:1000), PP2 (Sigma-Aldrich, 10 uM), recombinant SerpinA12 (R&Dsystems, 100 ng/mL), Akt inhibitor (Tocris, Akti-1/2, 250 nM), PQ-401 (Tocris, 10uM) and AMPK inhibitor (Tocris, Dorsomorphin dihydrochloride, 20 uM).

Techniques: Staining, In Vitro, Protein Array, Expressing

(A) Representative WB and densitometry quantification for Igfbp3 and SerpinA12 from plasma from control subjects and with alcoholic hepatitis. Subjects with alcoholic hepatitis have significative higher levels of Igfbp3 and significative lower levels of SerpinA12 compared to controls (n=9, p<0.05, unpaired t-test). (B) Schematic representation of the proposed mechanism of hepatic stellate cells (HSC)-activation-induced steatosis. Activated HSC increase Insulin-like growth factor-binding protein 3 (Igfbp3) and reduces SerpinA12 secretion, which have a paracrine effect over hepatocytes. Igfbp3 increases p-Akt signaling through integrin receptor leading to lipid droplets formation, triglyceride content, and lipogenic gene expression; EtOH reduces p-AMPK, increasing lipogenesis. SerpinA12 protects against ethanol-induced steatosis through increasing p-AMPK.

Journal: Journal of hepatology

Article Title: Hepatic stellate cell activation promotes alcohol-induced steatohepatitis through Igfbp3 and SerpinA12

doi: 10.1016/j.jhep.2020.02.005

Figure Lengend Snippet: (A) Representative WB and densitometry quantification for Igfbp3 and SerpinA12 from plasma from control subjects and with alcoholic hepatitis. Subjects with alcoholic hepatitis have significative higher levels of Igfbp3 and significative lower levels of SerpinA12 compared to controls (n=9, p<0.05, unpaired t-test). (B) Schematic representation of the proposed mechanism of hepatic stellate cells (HSC)-activation-induced steatosis. Activated HSC increase Insulin-like growth factor-binding protein 3 (Igfbp3) and reduces SerpinA12 secretion, which have a paracrine effect over hepatocytes. Igfbp3 increases p-Akt signaling through integrin receptor leading to lipid droplets formation, triglyceride content, and lipogenic gene expression; EtOH reduces p-AMPK, increasing lipogenesis. SerpinA12 protects against ethanol-induced steatosis through increasing p-AMPK.

Article Snippet: Compounds used were murine or human recombinant Igfbp3 (R&D systems, 0.3 μg/mL), Cytochalasin D (Sigma-Aldrich, 1:1000), PP2 (Sigma-Aldrich, 10 uM), recombinant SerpinA12 (R&Dsystems, 100 ng/mL), Akt inhibitor (Tocris, Akti-1/2, 250 nM), PQ-401 (Tocris, 10uM) and AMPK inhibitor (Tocris, Dorsomorphin dihydrochloride, 20 uM).

Techniques: Activation Assay, Binding Assay, Expressing